Views & Analysis Digital health round-up: Apple's 'one-stop shop' Can Apple succeed where others can't?
Views & Analysis Verily, Novartis join fund to support Europe’s biotech entre... New $300m fund aimed at helping European biotechs to grow, providing alternative to an IPO or 'generally suboptimal' licensing or big pharma acquisition
Views & Analysis Digital health round-up: Apple ventures into the Land of Nod Apple becomes first 'big tech' firm to investigate sleep technology.
News Verily launches ambitious Project Baseline Study will create a comprehensive database reference for researchers.
News Verily unveils the Study Watch, a clinical trials-only weara... Device will be used in several upcoming clinical studies.
Views & Analysis Why Novartis and Verily should abandon their smart lens idea Technical officer hinted that the firm has hit obstacles to its ambitious projects.
News ADA: AZ reveals oral GLP-1 data in obesity, diabetes AstraZeneca prepares to move its oral GLP-1 elecoglipron into phase 3 for obesity and diabetes, after reporting encouraging phase 2b data at ADA.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
